| 32 Patients with malignant SPNs | 33 Patients with benign SPNs | 29 Healthy controls |
---|---|---|---|
Age, Median (SD) | 66.2 (8.3) | 64.7 (12.9) | 66.5 (7.1) |
Sex | Â | Â | Â |
   Female | 12 (37.5%) | 13(39.4%) | 10 (34.5%) |
   Male | 20 (62.5%) | 20 (60.6%) | 19 (65.5%) |
Race | Â | Â | Â |
   African American | 8 (25.0%) | 9 (27.3%) | 8 (27.6%) |
   White | 24 (75.0%) | 24 (72.7%) | 21 (72.4%) |
Nodule size, Median (SD) | 2.6 (1.8) | 1.1 (1.7) | Â |
Pack-years, Median (SD) | 35.5 (26.8) | 30.0 (30.2) | 35.0 (22.8) |
Stages of NSCLC | Â | Â | Â |
   stage I | 11 (34.4%) |  |  |
   stage II | 8 (25.0%) |  |  |
   stage III-IV | 13 (40.6%) |  |  |
Histological types of NSCLC | Â | Â | Â |
   AC | 18 (56.3%) |  |  |
   SCC | 14 (43.7%) |  |  |
Diagnosis of benign SPNs | Â | Â | Â |
   Inflammatory lesion |  | 27 (81.8%) |  |
   Sarcoid |  | 3 (9.1%) |  |
   Granuloma |  | 2 (6.1%) |  |
   Fibrosis |  | 1 (3.0%) |  |